Acute coronary syndrome secondary to paradoxical bronchospasm due to nebulized ipratropium bromide
نویسنده
چکیده
Ipratropium bromide is a muscarinic receptor antagonist used worldwide for management of chronic obstructive pulmonary disease (COPD) and acute asthma. It is considered a safe drug. Most common anticholinergic adverse effects are dry mouth, constipation and urinary retention. Cardiac and respiratory disorders are considered rare. We report a case of acute coronary syndrome secondary to its use. Correspondence to: Ramón Baeza-Trinidad, Department of Internal Medicine, Hospital San Pedro (Logrono), Spain, Tel: 941 29 80 00; E-mail: rbaezat@ riojasalud.es
منابع مشابه
Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial.
OBJECTIVE To compare the outcome of patients with acute bronchospasm treated with continuously nebulized albuterol plus ipratropium bromide vs albuterol alone. SETTING The Emergency Department (ED) at the University of California San Francisco Medical Center. PARTICIPANTS Patients > or = 18 years old presenting to the ED with acute bronchospasm and a peak expiratory flow rate (PEFR) of < 70...
متن کاملRandomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation.
OBJECTIVE To determine whether the addition of inhaled ipratropium bromide to inhaled albuterol and systemic corticosteroid therapy was more efficacious than inhaled albuterol and systemic corticosteroids alone in the inpatient treatment of acute asthma exacerbations in children. DESIGN Double-blind, randomized, placebo-controlled trial. SETTING Pediatric inpatient unit of a tertiary urban ...
متن کاملEffect of nebulized ipratropium bromide on intraocular pressures in children.
STUDY OBJECTIVE To evaluate the effects of nebulized ipratropium bromide on intraocular pressures and pupillary responses in children with asthma. DESIGN A double-blind, randomized, crossover study. SETTING Children's Hospital of Winnipeg, University of Manitoba. PATIENTS OR PARTICIPANTS Age 6 to 17 years with asthma. INTERVENTION Nebulized ipratropium bromide added to albuterol sulfate...
متن کاملRandomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
BACKGROUND In acute severe asthma, treatment must be initiated early to reverse the pathophysiology that may render airways less responsive to bronchodilation. The addition of nebulized ipratropium bromide to initial emergency department therapy improves pulmonary function, but it is unclear whether this approach results in earlier hospital discharge. The early use of bolus intravenous salbutam...
متن کامل